Genvax Technologies Closes its Seed Funding Round
Genvax Technologies, a startup dedicated to bringing advances in RNA vaccine production to animal health, announced it has closed its Series Seed Plus funding. This … Read more…
Genvax Technologies, a startup dedicated to bringing advances in RNA vaccine production to animal health, announced it has closed its Series Seed Plus funding. This … Read more…
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, raised US$112 million in Series C financing. SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis co-led … Read more…
Orbis Medicines, a Denmark-based oral macrocycle drug discovery company, raised €90 million in Series A funding. New Enterprise Associates (NEA) led the investment round with … Read more…